Product Information
CIPROFLOX-DEXAMETH OTIC SUSP is a generic product labeled by Sandoz Inc., priced at $7.1238 per ML under NDC 00781618667. Its NADAC has been published 311 times since Oct 21, 2020.
FDA first approved this application on Jul 18, 2003. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
3; 1 mg/mL; mg/mL
Manufacturer
Sandoz Inc.NDC
00781618667
Classification
Generic
Dosage Form
SUSPENSION/ DROPS
Route
AURICULAR (OTIC)
Effective Date
9/23/2026
Active Ingredients
CIPROFLOXACIN HYDROCHLORIDE; DEXAMETHASONEApproval Type
Authorized Generic (NDA)
FDA Application
NDA021537FDA Approved
7/18/2003
TE Code
AB
On Market Since
8/10/2020
Pharmacological Classes
Price Statistics
The NADAC for CIPROFLOX-DEXAMETH OTIC SUSP has been published 311 times since Oct 21, 2020, and over the history we have for it it has declined 66.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $7.1238 per ML |
|---|---|
| All-time high | $21.6787 (Jan 13, 2021) |
| All-time low | $6.9454 (Aug 19, 2026) |
| 52-week high | $9.8982 |
| 52-week low | $6.9454 |
| Median price | $17.5545 |
| Average price | $15.6124 |
| Largest weekly change | -39.8% (Nov 20, 2024) |
| Weeks tracked | 311 |
| Tracking since | Oct 21, 2020 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the ciprofloxacin and dexamethasone market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Sandoz Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
ciprofloxacin and dexamethasone market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CIPROFLOX-DEXAMETH OTIC SUSP?
The current National Average Drug Acquisition Cost (NADAC) for CIPROFLOX-DEXAMETH OTIC SUSP, manufactured by Sandoz Inc., is $7.1238 per ML (NDC 00781618667), effective Sep 30, 2026.
How has the price of CIPROFLOX-DEXAMETH OTIC SUSP changed over time?
Over the history we have for it, the NADAC for CIPROFLOX-DEXAMETH OTIC SUSP has declined 66.4%. It has been tracked across 311 weekly CMS publications since Oct 21, 2020.
What are the highest and lowest recorded NADAC prices for CIPROFLOX-DEXAMETH OTIC SUSP?
Since Oct 21, 2020, the NADAC for CIPROFLOX-DEXAMETH OTIC SUSP has ranged from a low of $6.9454 (Aug 19, 2026) to a high of $21.6787 (Jan 13, 2021), with a median of $17.5545 per ML.
Are there cheaper alternatives to CIPROFLOX-DEXAMETH OTIC SUSP?
No other NADAC-published product currently shares the active ingredient and strength of CIPROFLOX-DEXAMETH OTIC SUSP in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures CIPROFLOX-DEXAMETH OTIC SUSP?
CIPROFLOX-DEXAMETH OTIC SUSP (NDC 00781618667) is labeled by Sandoz Inc., and CMS classifies it as a generic product.